Man Group PLC Infinity Pharmaceuticals, Inc. Transaction History

Man Group PLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$0.59 - $1.7 $1,310 - $3,777	-2,222 Reduced 16.77%	11,025 $13,000
Q2 2022 Aug 15, 2022	BUY	$0.49 - $1.2 $6,491 - $15,896	13,247 New	13,247 $8,000
Q4 2018 Feb 14, 2019	SELL	$1.01 - $2.78 $14,538 - $40,018	-14,395 Closed	0 $0
Q3 2018 Nov 14, 2018	SELL	$1.72 - $2.71 $12,908 - $20,338	-7,505 Reduced 34.27%	14,395 $39,000
Q1 2018 May 15, 2018	BUY	$1.8 - $2.74 $39,420 - $60,006	21,900 New	21,900 $46,000

1.26M

Ticker INFI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 89,277,904
Description
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Its product candidate is IPI-549, an orally administered clinical-stage immuno-oncology product candidate that inhibits the enzyme phosphoinositide-3-kinase-gamma, which is in Phase 2 clinical trials for the treatment of met...

Get notified when there are updates to the investment portfolio of Man Group PLC, based on Form 13F filings with the SEC.

Stay updated on Man Group PLC with notifications on news.